H6PD and Alzheimer disease: The liraglutide-mediated increase in G6PDH activity and decreased pyruvate levels in mature female mice with early AD-like pathology suggest that its antioxidant effects may involve the stimulation of the oxidative branch of the pentose phosphate pathway (rather than glycolysis) and/or a decrement in p62 levels.